Cargando…
Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
AIMS: Chronic inflammation is a risk factor for cardiovascular disease (CVD). IL‐6 signalling perturbation through IL‐6 or IL‐6R blockade may have potential benefit on cardiovascular risk. It is unknown whether targeting either IL‐6 or IL‐6 receptor may result in similar effects on CVD and adverse e...
Autores principales: | Cupido, Arjen J., Asselbergs, Folkert W., Natarajan, Pradeep, Ridker, Paul M., Hovingh, G. Kees, Schmidt, A. Floriaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303316/ https://www.ncbi.nlm.nih.gov/pubmed/34931349 http://dx.doi.org/10.1111/bcp.15191 |
Ejemplares similares
-
Low‐Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific
por: Cupido, Arjen J., et al.
Publicado: (2022) -
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization
por: Cupido, Arjen J., et al.
Publicado: (2022) -
Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023) -
IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study
por: Sundaresh, Aparna, et al.
Publicado: (2019) -
The IL6 Gene Promoter SNP and Plasma IL-6 in Response to Diet Intervention
por: Rana, Brinda K., et al.
Publicado: (2017)